BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 25022372)

  • 1. The role of serum carcinoembryonic antigen in predicting responses to chemotherapy and survival in patients with non-small cell lung cancer.
    Liu H; Gu X; Lv T; Wu Y; Xiao Y; Yuan D; Li Y; Song Y
    J Cancer Res Ther; 2014; 10(2):239-43. PubMed ID: 25022372
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum carcinoembryonic antigen level as a surrogate marker for the evaluation of tumor response to chemotherapy in nonsmall cell lung cancer.
    Ishiguro F; Fukui T; Mori S; Katayama T; Sakakura N; Hatooka S; Mitsudomi T
    Ann Thorac Cardiovasc Surg; 2010 Aug; 16(4):242-7. PubMed ID: 21057440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinoembryonic antigen as prognostic factor for metastatic non-small cell lung cancer by percutaneous cryosurgery.
    Li H; Tang K; Niu L; Liang Y; Li J; Chen J; Xu K
    Cancer Biomark; 2013; 13(5):337-43. PubMed ID: 24440973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Usefulness of serum carcinoembryonic antigen (CEA) in evaluating response to chemotherapy in patients with advanced non small-cell lung cancer: a prospective cohort study.
    Arrieta O; Villarreal-Garza C; Martínez-Barrera L; Morales M; Dorantes-Gallareta Y; Peña-Curiel O; Contreras-Reyes S; Macedo-Pérez EO; Alatorre-Alexander J
    BMC Cancer; 2013 May; 13():254. PubMed ID: 23697613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer.
    Ardizzoni A; Cafferata MA; Tiseo M; Filiberti R; Marroni P; Grossi F; Paganuzzi M
    Cancer; 2006 Dec; 107(12):2842-9. PubMed ID: 17103443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of carcinoembryonic antigen and CYFRA21-1 in patients with pathological stage I non-small cell lung cancer.
    Matsuoka K; Sumitomo S; Nakashima N; Nakajima D; Misaki N
    Eur J Cardiothorac Surg; 2007 Sep; 32(3):435-9. PubMed ID: 17611117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preoperative serum carcinoembryonic antigen level is a prognostic factor in women with early non-small-cell lung cancer.
    Hsu WH; Huang CS; Hsu HS; Huang WJ; Lee HC; Huang BS; Huang MH
    Ann Thorac Surg; 2007 Feb; 83(2):419-24. PubMed ID: 17257963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Significance of the serum carcinoembryonic antigen level during the follow-up of patients with completely resected non-small-cell lung cancer.
    Ozeki N; Fukui T; Taniguchi T; Usami N; Kawaguchi K; Ito S; Sakao Y; Mitsudomi T; Hirakawa A; Yokoi K
    Eur J Cardiothorac Surg; 2014 Apr; 45(4):687-92. PubMed ID: 23979987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The relationship between Glasgow Prognostic Score and serum tumor markers in patients with advanced non-small cell lung cancer.
    Jiang AG; Chen HL; Lu HY
    BMC Cancer; 2015 May; 15():386. PubMed ID: 25956656
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Variations in Serum CEA and CYFRA21-1 Levels Before and After Surgery Facilitate Prognosis of Non-small Cell Lung Cancer Patients].
    Duan X; Cui Y; Gong M; Tian F; Shi G; Wu B; Liu M; Guo J; Kong Y
    Zhongguo Fei Ai Za Zhi; 2015 Jun; 18(6):358-64. PubMed ID: 26104892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Persistently high serum carcinoembryonic antigen levels after surgery indicate poor prognosis in patients with stage I non-small-cell lung cancer.
    Wang CY; Huang MS; Huang MH; Lee HC; Hsu HS
    J Surg Res; 2010 Oct; 163(2):e45-50. PubMed ID: 20638687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The function of the level of serum carcinoembryonic antigen on early recurrence of non-small cell lung cancer].
    Zhang ZF; Ma JQ; Sun N; Zhang L
    Zhonghua Wai Ke Za Zhi; 2004 Jul; 42(13):817-9. PubMed ID: 15363304
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-small-cell lung cancer prognosis using carcinoembryonic antigen levels in pleural lavage fluid.
    Tsutani Y; Yamashita Y; Misumi K; Ikeda T; Miyata Y; Okada M
    Eur J Cardiothorac Surg; 2012 Nov; 42(5):e96-101. PubMed ID: 22906597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of prognostic factors of non-small cell lung cancer in patients under 40 years of age].
    Xu CH; Yu LK; Zhang Y; Xie HY; Hao KK; Hu W; Xia N; Zhan P
    Zhonghua Zhong Liu Za Zhi; 2012 Sep; 34(9):703-5. PubMed ID: 23159086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Role of Change Rates of CYFRA21-1 and CEA in Predicting Chemotherapy Efficacy for Non-Small-Cell Lung Cancer.
    Zhao T; Mao G; Chen M
    Comput Math Methods Med; 2021; 2021():1951364. PubMed ID: 34603482
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of a prognostic model using blood biomarker information for prediction of survival of non-small-cell lung cancer patients treated with combined chemotherapy and radiation or radiotherapy alone (NCT00181519, NCT00573040, and NCT00572325).
    Dehing-Oberije C; Aerts H; Yu S; De Ruysscher D; Menheere P; Hilvo M; van der Weide H; Rao B; Lambin P
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):360-8. PubMed ID: 20888135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive role of CEA and CYFRA 21-1 in patients with advanced-stage NSCLC treated with erlotinib.
    Fiala O; Pesek M; Finek J; Benesova L; Minarik M; Bortlicek Z; Topolcan O
    Anticancer Res; 2014 Jun; 34(6):3205-10. PubMed ID: 24922695
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of serum carcinoembryonic antigen in prediction of chemotherapy efficacy and prognosis in patients with advanced non-small cell lung cancer treated with EGFR-tyrosine kinase inhibitor].
    Xu CA; Su H; Liu JL; Li L; Zou HW
    Zhonghua Zhong Liu Za Zhi; 2011 Jun; 33(6):436-41. PubMed ID: 21875484
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic and predictive significance of plasma hepatocyte growth factor and carcinoembryonic antigen in non-small lung cancer after surgery.
    Fang MY; Wang SY; Zheng YB; Gong LY; Bao WL; Gu DL; Mao WM
    Eur Rev Med Pharmacol Sci; 2014; 18(3):398-403. PubMed ID: 24563441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic value of carcinoembryonic antigen in T1N1M0 and T2N1M0 non-small cell carcinoma of the lung.
    Fukai R; Sakao Y; Sakuraba M; Oh S; Shiomi K; Sonobe S; Saitoh Y; Miyamoto H
    Eur J Cardiothorac Surg; 2007 Sep; 32(3):440-4. PubMed ID: 17643308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.